PD-MIND: Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Project: Research

Project Details

AcronymPD-MIND
StatusFinished
Effective start/end date1/05/202030/04/2023

Collaborative partners

  • King's College London (lead)
  • University of Exeter
  • University of Stavanger
  • University of Chieti-Pescara
  • TU Dresden
  • Norges Parkinsonforbund
  • LYGATURE
  • Masaryk University
  • AstraZeneca AB
  • Parkinson's UK

Funding

  • EC European Commission: £830,767.00